https://druglandscape.com/glossary2026-05-14monthly0.7 https://druglandscape.com/glossary/nda2026-05-14yearly0.6 https://druglandscape.com/glossary/bla2026-05-14yearly0.6 https://druglandscape.com/glossary/pdufa-date2026-05-14yearly0.6 https://druglandscape.com/glossary/priority-review2026-05-14yearly0.6 https://druglandscape.com/glossary/breakthrough-therapy2026-05-14yearly0.6 https://druglandscape.com/glossary/accelerated-approval2026-05-14yearly0.6 https://druglandscape.com/glossary/orphan-drug2026-05-14yearly0.6 https://druglandscape.com/glossary/phase-1-trial2026-05-14yearly0.6 https://druglandscape.com/glossary/phase-2-trial2026-05-14yearly0.6 https://druglandscape.com/glossary/phase-3-trial2026-05-14yearly0.6 https://druglandscape.com/glossary/primary-endpoint2026-05-14yearly0.6 https://druglandscape.com/glossary/surrogate-endpoint2026-05-14yearly0.6 https://druglandscape.com/glossary/mechanism-of-action2026-05-14yearly0.6 https://druglandscape.com/glossary/pharmacokinetics2026-05-14yearly0.6 https://druglandscape.com/glossary/pharmacodynamics2026-05-14yearly0.6 https://druglandscape.com/glossary/drug-interaction2026-05-14yearly0.6 https://druglandscape.com/glossary/adverse-event2026-05-14yearly0.6 https://druglandscape.com/glossary/boxed-warning2026-05-14yearly0.6 https://druglandscape.com/glossary/patent-cliff2026-05-14yearly0.6 https://druglandscape.com/glossary/paragraph-iv2026-05-14yearly0.6 https://druglandscape.com/glossary/orange-book2026-05-14yearly0.6 https://druglandscape.com/glossary/biosimilar2026-05-14yearly0.6 https://druglandscape.com/glossary/generic-drug2026-05-14yearly0.6 https://druglandscape.com/glossary/rems2026-05-14yearly0.6 https://druglandscape.com/glossary/nice2026-05-14yearly0.6 https://druglandscape.com/glossary/qaly2026-05-14yearly0.6 https://druglandscape.com/glossary/cdx2026-05-14yearly0.6 https://druglandscape.com/glossary/ind2026-05-14yearly0.6 https://druglandscape.com/glossary/faers2026-05-14yearly0.6 https://druglandscape.com/glossary/ema2026-05-14yearly0.6 https://druglandscape.com/glossary/chmp2026-05-14yearly0.6 https://druglandscape.com/glossary/epar2026-05-14yearly0.6 https://druglandscape.com/glossary/pdufa2026-05-14yearly0.6 https://druglandscape.com/glossary/crl2026-05-14yearly0.6 https://druglandscape.com/glossary/adcom2026-05-14yearly0.6 https://druglandscape.com/glossary/ind2026-05-14yearly0.6 https://druglandscape.com/glossary/cta2026-05-14yearly0.6 https://druglandscape.com/glossary/os2026-05-14yearly0.6 https://druglandscape.com/glossary/pfs2026-05-14yearly0.6 https://druglandscape.com/glossary/orr2026-05-14yearly0.6 https://druglandscape.com/glossary/hr-clinical2026-05-14yearly0.6 https://druglandscape.com/glossary/p-value2026-05-14yearly0.6 https://druglandscape.com/glossary/itt2026-05-14yearly0.6 https://druglandscape.com/glossary/nnt2026-05-14yearly0.6 https://druglandscape.com/glossary/recist2026-05-14yearly0.6 https://druglandscape.com/glossary/gmp2026-05-14yearly0.6 https://druglandscape.com/glossary/ich2026-05-14yearly0.6 https://druglandscape.com/glossary/pmda2026-05-14yearly0.6 https://druglandscape.com/glossary/nice-ta2026-05-14yearly0.6 https://druglandscape.com/glossary/icer-cost2026-05-14yearly0.6 https://druglandscape.com/glossary/wac2026-05-14yearly0.6 https://druglandscape.com/glossary/nadac2026-05-14yearly0.6 https://druglandscape.com/glossary/asp2026-05-14yearly0.6 https://druglandscape.com/glossary/340b2026-05-14yearly0.6 https://druglandscape.com/glossary/ira2026-05-14yearly0.6 https://druglandscape.com/glossary/cro2026-05-14yearly0.6 https://druglandscape.com/glossary/cmo2026-05-14yearly0.6 https://druglandscape.com/glossary/protac2026-05-14yearly0.6 https://druglandscape.com/glossary/adc2026-05-14yearly0.6 https://druglandscape.com/glossary/car-t2026-05-14yearly0.6 https://druglandscape.com/glossary/mab2026-05-14yearly0.6 https://druglandscape.com/glossary/mrna-therapy2026-05-14yearly0.6 https://druglandscape.com/glossary/nct2026-05-14yearly0.6 https://druglandscape.com/glossary/bpcia2026-05-14yearly0.6 https://druglandscape.com/glossary/hatch-waxman2026-05-14yearly0.6 https://druglandscape.com/glossary/anda2026-05-14yearly0.6 https://druglandscape.com/glossary/moa2026-05-14yearly0.6 https://druglandscape.com/glossary/otc2026-05-14yearly0.6 https://druglandscape.com/glossary/tga2026-05-14yearly0.6 https://druglandscape.com/glossary/pbac2026-05-14yearly0.6 https://druglandscape.com/glossary/hta2026-05-14yearly0.6 https://druglandscape.com/glossary/pharmacovigilance2026-05-14yearly0.6 https://druglandscape.com/glossary/nce2026-05-14yearly0.6 https://druglandscape.com/glossary/off-label2026-05-14yearly0.6 https://druglandscape.com/glossary/indication2026-05-14yearly0.6